Healthcare
Vera Therapeutics, Inc.
VERAPrice is delayed.
About Vera Therapeutics, Inc.
Vera Therapeutics is a biotechnology company developing drugs to treat autoimmune diseases, where the immune system attacks the body's own cells. The company's main focus is atacicept, a drug given as a home injection that is being tested to treat immunoglobulin A nephropathy, a disease that damages the kidneys. Vera is also working on two other experimental drugs: one to treat serious viral infections and another to treat various autoimmune conditions. The company is still in clinical testing stages and has not yet brought any drugs to market.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore